Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910743 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Diana-Andreea Ciortea und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, University "Dunarea de Jos" of Galati, 800201 Galati, Romania. Hauptthemen laut MEDLINE: Glycopeptides, Polyuria, Polydipsia, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pediatric patients with polyuria polydipsia syndrome (PPS) represent a diagnostic challenge for clinicians because of the technical difficulties in performing the gold standard water deprivation test (WDT). Copeptin, a stable biomarker representing the C-terminal portion of the polypeptide chain of the antidiuretic hormone, is a reliable diagnostic tool. To assess the diagnostic accuracy of baseline copeptin dosing, arginine/hypertonic saline copeptin stimulation tests, and WDT. This study aimed to establish the diagnostic utility of copeptin in pediatric patients by distinguishing between central diabetes insipidus, nephrogenic diabetes insipidus, and primary polydipsia. Comparative and non-comparative primary studies published between January 2018 and August 2024 focusing on children were searched and included in PubMed, Cochrane Library, Web of Science, ScienceDirect, Scopus, and Google Scholar. The QUADAS-2 tool was used to assess the risk of bias and applicability. Meta-analyses used fixed effects models because of low heterogeneity and the HSROC model. Eleven studies were included with an overall low bias and no significant applicability concerns. The mean pooled sensitivity = 0.98 (95% CI: 0.936–1.025), pooled specificity = 0.947 (95% CI: 0.920–0.973), and AUC = 0.972 (95% CI: 0.952–0.992), indicating excellent diagnostic accuracy. Stimulation methods for copeptin dosing represent an effective and less invasive diagnostic test for children with PPS, and future development of standard copeptin testing protocols is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Pharmacy, University "Dunarea de Jos" of Galati, 800201 Galati, Romania.
- Emergency Clinical Hospital for Children "Maria Sklodowska Curie", 041451 Bucharest, Romania.
- Emergency Clinical Hospital for Children "Sf Ioan", 800487 Galati, Romania.
- Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 030167 Bucharest, Romania.
- Emergency Clinical Hospital for Children "Grigore Alexandrescu", Department of Pediatrics, 011743 Bucharest, Romania.
ORCID-Profile: Carmen Loredana Petrea Cliveți, Iolanda Cristina Vivisenco, Gabriela Gurău
Zitieren
APA
Ciortea, D. A., Petrea Cliveți, C. L., Bujoreanu Bezman, L., Vivisenco, I. C., Berbece, S. I., Gurău, G., Matei, M. N., & Nechita, A. (2024). Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910743
Vancouver
Ciortea DA, Petrea Cliveți CL, Bujoreanu Bezman L, Vivisenco IC, Berbece SI, Gurău G, et al. Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910743
BibTeX
@article{Ciortea2024,
author = {Ciortea, Diana-Andreea and Petrea Cliveți, Carmen Loredana and Bujoreanu Bezman, Laura and Vivisenco, Iolanda Cristina and Berbece, Sorin Ion and Gurău, Gabriela and Matei, Mădălina Nicoleta and Nechita, Aurel},
title = {Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910743}
}
EUVIMED